NVIDIA Keeps Falling and Wall Street Won't Move Its Target. Is It Time To Buy?

NVIDIA reported fiscal Q2 2027 revenue of $96.22 billion, up 105.85% and above the $92.07 billion estimate; EPS of $2.22 also beat consensus, and Data Center revenue rose 117% to $89.023 billion. Despite the results, shares fell 8.91% in a week and traded at $216.30; 24/7 Wall St. assigns a $263.54 target and a Buy rating with 90% confidence, while the consensus analyst target is $328.72. Management guided to $108 billion in fiscal Q3 revenue, but supply commitments, rising days sales outstanding, margin pressure and China revenue exclusions remain risks.

Analysis

The price/business divergence is not, by itself, a buy signal: it suggests investors are discounting the durability and funding quality of demand rather than the latest quarter. The key second-order risk is the customer-financing loop. Longer collection times alongside large supply commitments make reported demand less informative unless hyperscalers and GPU-cloud customers convert capex into timely cash receipts. A pullback in spending could therefore hit utilization and payment quality before it appears in NVIDIA’s reported revenue.

Over the next several weeks, positioning and expectations around the November 17 report can dominate fundamentals; a strong beat may not lift the stock if the Vera Rubin schedule, margins, or cash conversion disappoint. Over 1–3 months, verify customer capex plans, days sales outstanding, gross-margin trajectory, and whether supply commitments translate into shipments. Over 6–18 months, custom accelerators from Broadcom and continued AMD competition are credible substitution risks, while memory costs can constrain NVIDIA’s margin recovery and support Micron only if pricing and demand remain firm.

The article’s model target and stated confidence are not independent evidence of fair value. The apparent valuation discount to AMD is also insufficient for a short: different earnings bases and growth profiles make that comparison fragile. The bullish thesis is falsified by hyperscaler capex cuts, repeated product-ramp delays, deteriorating collections, or margin guidance moving below the stated recovery path.

Key Decisions for Investors

• Use a staged, modest NVDA entry rather than buying the dip at full size. Add only if the November 17 update supports the product ramp and cash conversion; reduce or exit on capex cuts, worsening collections, or a margin outlook below management’s stated path. Upside depends on continued supply-constrained growth; downside is a rapid multiple reset if demand proves financing- or utilization-dependent.
• For investors seeking defined event risk, consider a small, limited-risk NVDA call spread into the report only if premiums are reasonable; avoid naked calls. The catalyst is confirmation of the ramp, while a guidance or cash-conversion disappointment can overwhelm an earnings beat. If implied volatility is elevated, wait until after the report rather than paying for event premium.
• Do not short AMD solely on the article’s trailing-multiple comparison, and do not treat Broadcom as a clean hedge: custom chips can gain share while overall AI spending expands. Monitor Micron as a conditional memory-cost beneficiary, not an automatic long; confirm memory pricing and demand before acting.